TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/25/2024
Back to search
Official data from USPTO
MIRATI THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
06/25/2024
Trademark type
Combined
Nice classes
42
Filing date
05/27/2021
Registration date
04/26/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/26/2022
Last transaction
06/25/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2013-05-00
First use in commerce
2013-05-00
Drawing code
5
Owner type
03
Owner location
San Diego, CA, US
Examiner
HSU, FONG
Law office
O20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a stylized term MIRATI above a stylized term THERAPEUTICS.
Holders and representatives
Holders
Mirati Therapeutics, Inc.
Representatives
Marilyn F. Kelly Bristol-Myers Squibb Company
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals
Publications
History of USPTO decisions and trademark events.
19 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/25/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/25/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
04/26/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/08/2022
PUBO
PUBLISHED FOR OPPOSITION
02/08/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/19/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/05/2022
ALIE
ASSIGNED TO LIE
01/04/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/03/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/01/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/30/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/30/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/08/2021
GNRT
NON-FINAL ACTION E-MAILED
11/08/2021
CNRT
NON-FINAL ACTION WRITTEN
11/08/2021
DOCK
ASSIGNED TO EXAMINER
11/01/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/23/2021
NWAP
NEW APPLICATION ENTERED
05/31/2021
Continuous trademark protection
Get notified about every new filing that threatens MIRATI THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.